[Orphan medicinal products: assessment after 5 years of European legislation].
Borensztein
Pascale
P
GIS-Institut des maladies rares, Paris, France. pborensz@gis-maladiesrares.net
D017281:Cost of Illness; D005060:Europe; D009965:Orphan Drug Production / Q000191:economics*; D012109:Research Support as Topic